Discover Our Latest News

Restoring Proteostasis May Boost T Cell Function and Open a New Route for Immunotherapy

OPTIMAL Data Support TLX597-Tx as a Next-Gen Radioligand Therapy in Prostate Cancer

AidaBREAST Gains FDA Breakthrough Status for Personalized Radiotherapy in Breast Cancer

Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma

Real-World Analysis Links Community Oncology Care to Longer Survival in Multi-Cancer

Dual Pathway Blockade Achieves 40% Response in Clear Cell Gynaecological Cancer

Early CAR T-Cell Intervention Shows Disease-Eradication Potential in High-Risk Myeloma

World’s First Nectin-4-Targeting ADC Enters Phase III Trial in Triple-Negative Breast Cancer

Long-Term Data Show Taletrectinib Delivers High Response Rates in ROS1+ NSCLC

FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection

Opaganib Shows Dual Preclinical Promise in Neuroblastoma and Triple- Breast Cancer

Ozekibart Shows Encouraging Late-Line Activity in Metastatic Colorectal Cancer

FDA Grants Breakthrough Status to First Viral Liquid Biopsy in Hepatocellular Carcinoma

PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-R Solid Tumors

FDA Gives Priority Review to PADCEV Plus Pembrolizumab in MI Bladder Cancer

AACR26 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection

FDA Grants Breakthrough Status to First Urine-Based Multi-Cancer Early Detection Test

Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer

AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis

Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research

Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma

Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer

FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer

Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers

MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer

Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer

New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy

Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer

New Radio-Theranostic Promises to Broaden Targeted Radiation in Solid Tumors

FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas